An increased incidence of candidiasis and cryptococcosis has been recorded within the last two decades, mainly due to the increase in number of immunocompromised patients. Moreover, the emergence of resistant pathogenic yeast strains coupled with the shortcomings of the available antifungal drugs have emphasized the need of new drugs. Within this framework, this study aimed at investigating extracts from fourteen Annonaceae plants species in vitro against the major causative agents of mycoses, namely Candida albicans, Candida parapsilosis and Cryptococcus neoformans. Plant extracts and partitioned fractions were screened by broth dilution method. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of extracts were determined by microdilution method and subculture. Also, the effect of combined active hexane fraction (UAst H) of Uvaria angolensis stem extract with the reference ketoconazole was studied. MIC values ranged from 0.625 mg/mL (for the leaf extract of Uvaria banmanni-UBl) to ≥10 mg/mL. Fraction UAst H showed the broadest spectrum activity with MIC value of 2.5 mg/mL against all the tested yeasts. Moreover, UAst H exhibited synergistic interaction on C. albicans, Cr. neoformans and C. parapsilosis when combined with ketoconazole. Overall, the results achieved in this study are promising and indicate that plants species from Annonaceae family are possible sources of potent and synergistic anti-yeast extracts.
INTRODUCTION
The HIV pandemic has greatly increased the incidence of fungal infections over the last two decades (Khan et al., 2012; Okonkwo et al., 2013) . As the most implicated, Candida species are responsible for a variety of infections from superficial to systemic (Nucci and Marr, 2005; Romeo et al., 2013) . Candida albicans is the most frequently isolated (Ruhnke, 2006) , and is responsible for over 50% of candidemias (Hachem et al., 2008) , followed by C. parapsilosis (10%-20%), C. glabrata (20%-30%), C. tropicalis (17.3%) and C. krusei (1%-5 %) (Horn et al., 2009 ). In addition, HIV infection has been associated with more than 80% of cryptococcosis cases worldwide (Mirza et al. 2003; Perfect et al., 2010) with 100% mortality rate (Corbett et al., 2002) when untreated. The treatment of candidiosis and cryptococcosis is limited to drugs from few classes such as polyenes (amphotericin B, AMB), pyrimidine analogues (fluorocytosine), azoles and 1,3-betaglucan synthase inhibitors (echinocandins). However, the development of resistant pathogens along with high toxicity of these drugs have significantly impaired the control of fungal infections worldwide, stimulating the search for new, safe and more efficient drug candidates.
Plant-derived products for drugs discovery program have gained attention of scientific community since decades. In fact, medicinal plants have been the sources of variety of biologically active compounds for centuries and are used extensively as crude materials or as pure compounds for treating various conditions (Dias et al., 2012) . Within this context, Cameroonian medicinal plants have been investigated against a wide range of microorganisms (Fokou et al., 2014; Sidjui et al., 2014; Kammalac et al., 2015; Kamdem et al 2015; Menkem et al., 2015; Menkem et al., 2016 One hundred grams of powder from each plant part were macerated in 1500 mL of ethanol (Merck) for 72 h at room temperature (25-27 °C). Filtrates obtained using filter papers (Whatman no.1) were evaporated to dryness using a rotary evaporator at 80 °C (Büchi 011, Flawil Switzerland). Stock solution for each extract was prepared at 100mg/mL using 10% DMSO. As positive control, ketoconazole (Janssen-cilag) was prepared at 200 mg/mL in sterile distilled water. Each solution was sterilized by filtration through 0.22 µm sterile filter (Acrodisc Syringe Filter).
All extracts were screened by broth dilution method (CLSI, 2008) at 10mg/mL in 96-well microtiter plates. To achieve this, 10 µL of each stock solution of extract were added in triplicate wells followed by 90 µL of yeast inoculum prepared at 2.5×10 3 CFU/mL in sabouraud dextrose broth (Difco) medium. Wells containing 10% DMSO without extracts were used as negative control while ketoconazole was tested as positive control.
Plates were incubated at 37 °C for 48 h and extracts showing 100% inhibition of fungal growth against the three tested yeasts ascertained by macroscopic observation were selected and progressed. Fifteen grams of each selected extract were added to 150 mL of water and further fractionated by liquid-liquid partition between water and hexane (v/v) to yield hexane and aqueous fractions. Hexane fractions were dried using rotavapor while aqueous fractions were freeze dried to obtained powders. In some few cases, interface precipitates were obtained and also tested for biological activity. Stock solution for each fraction was prepared at 100 mg/mL using 10% DMSO. Phytochemical screening of the selected fraction The most active fraction was subjected to phytochemical screening to detect the presence of secondary metabolites with potential antifungal activity, namely saponins, tannins, flavonoids, phenols, alkaloids, triterpenes, anthocyanins, essential oils and steroids as described by (Odebeyi and Sofowora, 1978) . (Tobudic et al., 2010) . According to the adopted criteria, a combination was considered synergistic when the FICI was ≤ 0.5, additive when it was > 0.5 to ≤ 1, indifferent when it was > 1.0 to ≤ 4.0, and antagonistic when the obtained FICI was > 4.0.
RESULTS

Yields of plant extraction and anti-yeast potential of fourteen Annonaceae plants
Plant samples were extracted by maceration using ethanol, and the yield of extraction calculated relative to the weight of the starting plant material. Extracts were screened for activity against yeasts. The data collected are summarized in Table 2 .
The plants extraction yields varied from 0.10 to 13.94% and were highly dependent on the plants species and parts used. The preliminary antifungal screening also showed varying susceptibility of the tested yeasts. Amongst the 44 extracts prepared from 14 plants, only 13 (29.54%) inhibited the growth of all the tested yeasts, namely C. albicans, C. parapsilosis and Cr. neoformans at 10mg/ml, including AMfr, MMl, POl, POtw, POsb, PSl, UBl, UAl, UAtw, UAst, UMutw, UMust, and XPs. These promising extracts derived from different types of plant organ, including fruit, leaf, twig, stem, stem bark, and seed. They were selected and subjected to liquid-liquid partition coupled with MIC/MFC determination.
Determination of Anti-yeast activity parameters of promising extracts and their fractions Table 3 below summarizes the activity parameters (MIC and MFC) of 29 fractions derived from the 13 selected crude extracts against three pathogenic yeasts, namely C. albicans, C. parapsilosis, and Cr. neoformans.
The activities displayed spanned from 0.625 mg/mL to >10 mg/mL depending on the plant extracts and yeast species. The highest potency was exhibited by the crude leaf extract of Uvaria banmanni (UBl) against C. albicans with an MIC value of 0.625 mg/mL and MFC of 1.25 mg/mL. Besides, UBl only showed moderate effect against C. parapsilosis and Cr. neoformans with MIC of 10 mg/mL and MFC > 10 mg/mL. The other few active crude extracts inhibited the yeasts with MIC values ranging from 2.5 mg/mL to >10 mg/mL, and MFC from 5 mg/mL to >10 mg/mL. Amongst those, the more promising were MMl from the leaf of M. myristica, UAtw and UMutw from the twig of U. angolensis and U. muricata respectively and that showed MIC values of 5 mg/mL against the three yeasts. Extract POl from P. oliveri significantly inhibited Cr. neoformans with an MIC of 2.5 mg/mL and MFC of 5 mg/mL, but only showed moderate action against C. albicans and C. parapsilosis (MIC= 10 mg/mL).
As shown in Table 3 , water/hexane partition of the 13 extracts (AMfr, MMl, POl, POtw, POsb, PSl, UBl, UAl, UAtw, UAst, UMtw, UMst, and XPs) yielded 29 fractions that were equally tested for biological activity, including 3 interface precipitates, MMl I, POl I, and UBl I respectively from M. myristica (leaf), P. oliveri (leaf), and U. banmanni (leaf). The MIC values of these fractions ranged from 2.5 to >10 mg/ml. The most active was the hexanic fraction from the stem of U. angolensis (UAst H) that exhibited potent fungicidal effects against C. albicans and Cr. neoformans (MIC= 2.5 mg/mL; MFC= 5 mg/mL), and to a certain extent against C. parapsilosis (MIC= 2.5 mg/mL; MFC > 10 mg/mL). In this particular case, the partition of the mother crude extract has delivered a two-fold more potent hexanic fraction and an aqueous fraction with mother extract-like activity (MIC of 5 mg/mL; MFC > 10 mg/mL against C. parapsilosis and Cr. neoformans, and MIC of 10 mg/mL; MFC > 10 mg/mL against C. albicans). Besides, it was noticed that fractionation did not show any overall activity improvement from the other partitioned extracts. Consequently, fraction UAst H from the stem of U. angolensis was selected for further phytochemical screening and combination studies. 
DISCUSSION
Plants species from Annonaceae family are worldwide distributed and used all over the tropics in traditional medicine for the treatment of parasitic and microbial diseases, including fungal and bacterial infections. As reported by Tsabang et al (2012) , Annonaceae plants are widely used by Cameroonian traditional healers to cure malaria and related symptoms, and many other infections. Moreover, phytochemical studies of this family have revealed chemical components which could offer new alternatives for the treatment and control of several infectious diseases (Frausin et al., 2014) . Of note, secondary metabolites with antimicrobial activity from classes of alkaloids, flavonoids, tannins, phenolic compounds, anthocyanins, saponins, triterpenes, steroids, and acetogenins have been reported from many Annonaceae plant species (Leboeuf et al., 1980; Lewis and Ausubel, 2006; Taha et al 2013; Frausin et al., 2014; Liaw et al., 2016) .
From the present investigation, fourteen different plants species from eight genera were investigated for their potential to inhibit the growth of Candida albicans, Candida parapsilosis and Cryptococcus neoformans. The results showed that few extracts and fractions could inhibit the tested yeasts. Of particular interest, the hexane fraction (UAst H) obtained from the water/hexane partition of the stem extract of Uvaria angolensis exhibited potent inhibitory effects against the three pathogens, more likely due to its content in secondary metabolites that have been shown to possess antifungal activity. This active fraction has also exhibited remarkable synergistic activity in combination with Ketoconazole (FICI from 0.29-0.47) against the three pathogens.
The qualitative phytochemical screening of fraction UAst H has revealed the presence of phenols, flavonoids, triterpenes, steroids, saponins, anthocyanins, tannins, and essentials oils. These compounds have the potential to exhibit potent activity against yeasts alone or in combination. For instance, phenolic compounds isolated from natural sources possess antifungal properties of interest. Particularly, phenolic acids have shown promising in vitro and in vivo activity against Candida species. However, studies on their mechanism of action alone or in synergism with known antifungals are still scarce (Teodoro et al., 2015) . Also, flavonoids used in combination with fluconazole recently showed significant synergistic activity in vitro against Candida tropicalis strains resistant to fluconazole (Da Silva et al., 2014) . Similarly, condensed tannins from Stryphnodendron adstringens showed in vitro and in vivo effect on Candida tropicalis growth and adhesion properties (Morey et al., 2016) . Steroidal saponins have also been shown to exert significant activity against Cr. neoformans and Aspergillus fumigatus (Yang et al., 2006) . Limited studies have indicated that phenols, saponins and flavonoids might exert their antimicrobial action through membrane perturbations (Tsuchiya et al 1996; Majorie, 1999; Cushnie and Lamb, 2005) . As well, essential oils that are complex volatile compounds, synthesized naturally in different plant parts during the process of secondary metabolism have great potential in the field of biomedicine as they effectively destroy several bacterial, fungal, and viral pathogens. The presence of different types of aldehydes, phenolics, terpenes, and other antimicrobial compounds means that the essential oils are effective against a diverse range of pathogens.
A tentative explanation of the observed synergistic action of fraction UAst H in combination with ketoconazole might be the disruption of cell membrane coupled with the impairing effect of ketoconazole on the synthesis of membrane ergosterol (Ghannoum and Rice, 1999) . Furthermore, these results are consistent with previous studies where plant extracts were reported to increase in vitro efficacy of available antimicrobial drugs against bacteria and fungi (Betoni et al., 2006; Esimone et al., 2006; Horiuchi et al., 2007) .
Opportunistic fungal infections elicited by Candida, Cryptococcus, and Aspergillus are life-threatening in immunocompromised patients (with AIDS, cancer, or organ transplant) (Liu and Lian, 2003) . The currently prescribed antifungal drugs belong to five major drug classes, namely 1) polyenes (ex. Amphotericin B; interacting with fungal ergosterol, thereby disrupting the cytoplasmic membrane); 2) azoles (ex. Ketoconazole, fluconazole; inhibiting 14α-lanosterol demethylase in ergosterol biosynthesis pathway); 3) allylamines (ex. terbinafine, butenafine; inhibiting squalene epoxidase in ergosterol synthesis pathway), 4) echinocandins (ex. caspofungin, anidulafungin; inhibiting synthesis of β-1,3-glucan, which is a required component of the cell wall of many fungi), and 5) flucytosine (ex. flucytosine; incorporated into RNA and thus inhibiting DNA synthesis) (Ren, 2004) . Unfortunately, each of these drug classes have at least one major shortcomings such as significant dose-limiting toxicities for Amphotericin B, rapid development of resistance for the azoles, limitation of the use to dermatophytoses for terbinafine, and lack of effectiveness in cryptococcosis for caspofungin) (Marr et al., 2001 (Marr et al., , 1998 Liang and Wang, 2004) . This has emphasized the need to discover new antifungal agents, preferably with new modes of action. In fact, plant extracts can be used as synergistic enhancers even if they don't have any antimicrobial properties alone. They can enhance the effect of standard drugs when they are taken concurrently (Horiuchi et al., 2007) . Many attempt to formulate such combinations either with commercially available antifungals, or potent phytochemicals have been described (Sibanda and Okoh, 2007; Adwan and Mhanna, 2008) . In addition to the results described in this study, recent findings also support that plant extracts from Annonaceae have the potential to be further developed as drugs to control fungal diseases. For instance, methanol, chloroform, and aqueous extracts of Annona squamosa leaves recently showed activity against five different strains of fungi (Alternaria alternata, Candida albicans, Fusarium solani, Microsporum canis, and Aspergillus niger) (Kalidindi et al., 2015) . Also, antifungal activity of ethanolic, methanolic, and aqueous extracts of Annona muricata was recently reported against C. albicans and Cr. neoformans (Vinothini and Growther, 2016) . These previous findings further emphasize the potential of Annonaceae extracts as sources of potent antifungal agents.
Conclusion
The results from this investigation suggest that plants species from Annonaceae family can be used as promising sources for antifungal drug discovery. Moreover, the synergistic interaction of fraction UAst H from Uvavia angolensis with ketoconazole against the tested yeasts further suggest the possibility of development of novel synergistic antiyeast therapies from such extracts. However, in an optic to develop new drugs against opportunistic mycosis, further detailed studies of the selected fraction are required.
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